Clinical Trial Update: Effect of Prednisolone Treatment on Uterine Natural Killer Cells [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating prednisolone treatment on uterine natural killer cells for recurrent pregnancy loss is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Recurrent Miscarriage | Phase 3 | Status: RECRUITING